View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsNylex (Malaysia) Berhad 将来の成長Future 基準チェック /06現在、 Nylex (Malaysia) Berhadの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長49.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Mar 08Nylex to Delist from Bursa Malaysia on March 11Nylex (Malaysia) Berhad is set to be delisted from Bursa Malaysia on March 11, following the company’s failure to submit its regularisation plan on time. In a filing with Bursa Malaysia on March 6, 2025, the bourse regulator said it has dismissed the company's appeal for a further extension of six months until July 26, 2025 to submit its regularisation plan to the relevant authorities for approval. As such, Bursa Malaysia said the company would be delisted from Bursa Malaysia after two market days from March 6, that is on March 11, 2025. Upon the de-listing of the company, the company will continue to exist but as an unlisted entity. The company can still continue its operations and businesses and proceed with its corporate restructuring.お知らせ • Sep 27Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024, at 09:30 Singapore Standard Time. Location: no. 2a, jalan 13/2, seksyen 13, 46200 petaling jaya, selangor darul ehsan, Malaysiaお知らせ • Jan 31Nylex (Malaysia) Berhad Provides Update Related to Suspension & Delisting of SecuritiesRefer to the Nylex (Malaysia) Berhad’s announcements dated 27 January 2022 and 28 January 2022 in relation to the First Announcement and the announcements made on 16 August 2023, 23 August 2023, 13 October 2023 and 26 January 2024. Unless otherwise stated, all abbreviations and definitions used herein shall have the same meanings as those used in the said announcements. The Board announced that Bursa Securities had via its letter dated 29 January 2024 informed the Company that Bursa Securities has noted that: a) Nylex had failed to submit the proposed regularisation plan to the relevant authorities for approval within the extended timeframe of 26 January 2024 as granted by the Listing Committee via its letter dated 13 October 2023 (“LC Decision Letter”); and b) the Company has on 26 January 2024, appealed/applied for a further extension of time ("Appeal"). In the circumstances and pursuant to paragraph 8.03A(3) of the Listing Requirements and the LC Decision Letter, (i) the trading in the securities of Nylex will be suspended with effect from 7 February 2024 ("Suspension Date") even though the decision on the Appeal is still pending. (ii) However, the de-listing of the securities of the Company upon the expiry of 2 market days from the Suspension Date will be deferred pending the decision on the Appeal by Bursa Securities.New Risk • Jan 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RM40.5m (US$8.55m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM40.5m market cap, or US$8.55m). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change).お知らせ • Sep 27Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023, at 09:30 Singapore Standard Time. Location: No. 2A, Jalan 13/2, Seksyen 13,46200 Petaling Jaya Selangor Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31 May 2023 together with the Reports of the Directors and the Auditors; To re-elect as Director, Datin Joanne Marie Lopez who is retiring pursuant to Clause 130 of the Company's Constitution; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2023; to approve the payment of Non-Executive Directors' fees for the financial year ending 31 May 2024, to be paid quarterly in arrears; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorise the Directors to fix their remuneration and to consider other business matters.New Risk • Aug 18New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RM44.9m (US$9.66m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 12% per year over the past 5 years. Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM44.9m market cap, or US$9.66m).お知らせ • Jun 29+ 9 more updatesNylex (Malaysia) Berhad Announces Redesignation of Edmond Cheah Swee Leng from Chairman of Nomination and Remuneration Committee to Non Independent and Non Executive Member of Nomination and Remuneration CommitteeNylex (Malaysia) Berhad announced redesignation of EDMOND CHEAH SWEE LENG from Chairman of Nomination and Remuneration Committee to Non Independent and Non Executive Member of Nomination and Remuneration Committee. Age 68, Date of change 28 June 2023. Composition of Nomination and Remuneration Committee(Name and Directorate of members after change). Chairman: Datin Joanne Marie Lopez (Independent Non Executive Director) Members: Datuk Anuar Bin Ahmad (Independent Non Executive Director) Edmond Cheah Swee Leng (Non ndependent Non Executive Director).Board Change • Jan 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 5 highly experienced directors. Independent Non-Executive Director See Yan Lin was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Oct 04Full year 2022 earnings released: RM0.007 loss per share (vs RM0.004 loss in FY 2021)Full year 2022 results: RM0.007 loss per share (further deteriorated from RM0.004 loss in FY 2021). Net loss: RM1.26m (loss widened 70% from FY 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.お知らせ • Sep 29Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022, at 09:30 Singapore Standard Time. Location: No. 2a, Jalan 13/2, Seksyen 13, 46200 Petaling Jaya Darul Ehsan Selangor Malaysia Agenda: To receive the audited financial statements for the financial year ended 31 May 2022 together with the Reports of the Directors and the Auditors thereon; to re-elect the directors who are retiring by rotation; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2022; to approve the payment of Directors' benefits (excluding Non-Executive Directors' fees) for the Non-Executive Directors from the date of the forthcoming AGM until the next annual general meeting of the Company; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorize the Directors to fix their remuneration; to discuss proposed renewal authority for share buy-back mandate; and to discuss other matters.Reported Earnings • Jul 20Full year 2022 earnings released: RM0.28 loss per share (vs RM0.11 profit in FY 2021)Full year 2022 results: RM0.28 loss per share (down from RM0.11 profit in FY 2021). Revenue: RM934.1m (down 19% from FY 2021). Net loss: RM50.4m (down 367% from profit in FY 2021). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings.Reported Earnings • Apr 21Third quarter 2022 earnings released: RM0.32 loss per share (vs RM0.028 profit in 3Q 2021)Third quarter 2022 results: RM0.32 loss per share (down from RM0.028 profit in 3Q 2021). Revenue: RM273.8m (down 5.3% from 3Q 2021). Net loss: RM57.7m (down RM62.6m from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to RM1.53, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 13x in the Chemicals industry in Malaysia. Total returns to shareholders of 138% over the past three years.Upcoming Dividend • Mar 01Inaugural dividend of RM0.39 per shareEligible shareholders must have bought the stock before 08 March 2022. Payment date: 23 March 2022. The company is not currently making a profit and is not cash flow positive. The company last paid an ordinary dividend in September 2019. The average dividend yield among industry peers is 4.3%.お知らせ • Jan 27Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX).Ancom Berhad (KLSE:ANCOM) entered into an agreement to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on July 29, 2021. Ancom Berhad (KLSE:ANCOM) submitted a formal offer to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on April 28, 2021. Out of total consideration, MYR 50 million will be paid in cash and MYR 46.7 million via the issuance of 31,129,508 new Ancom Shares at an issue price of MYR 1.50 per Ancom Share. Post completion of the Proposed Acquisition, Ancom will continue to hold 50.27% equity interest in Nylex. The Cash Consideration will be funded through a bank borrowings. Out of total consideration, Nylex to distribute an amount equivalent to MYR 164.29 million to its shareholders and retain MYR 15 million for its working capital and general corporate purposes. The Proposed Acquisition is subject to approval of the shareholders of Ancom at an extraordinary general meeting to be convened; approval of Bursa Securities for the listing and quotation of the Consideration Shares on the Main Market of Bursa Securities; approval of the shareholders of Nylex at an EGM to be convened; regulatory approvals; approval/consent from financiers/creditors of Ancom, Rhodemark and/or the Nylex Group upon the terms and subject to the conditions of the Sale of Business Agreement, where required; grant of an order of the High Court of Malaya pursuant to Section 116 of the CA 2016 and other closing conditions. As of June 28, 2021, board of Nylex (Malaysia) Berhad accepted the offer. As of August 18, 2021, on behalf of the Ancom Board, Maybank IB wishes to announce that the additional listing application in relation to the Consideration Shares to be issued pursuant to the Proposed Acquisition has been submitted to Bursa Securities. As of September 23, 2021 on behalf of the Ancom Board, Maybank IB wishes to announce that Bursa Securities had via its letter dated September 23, 2021, approved the listing of and quotation for 31,129,508 new ordinary shares in Ancom to be issued pursuant to the Proposed Acquisition, subject to, among others conditions. The Proposal Letter shall remain valid for acceptance by the Nylex Board until 5.00 p.m. on June 28, 2021, unless extended by mutual agreement in writing and the parties are to negotiate and finalise the terms and conditions of the Sale of Business Agreement and enter into the Sale of Business Agreement within 60 days from the date of acceptance of the Proposal Letter (or such other period as the parties may agree in writing). The completion of the Proposed Acquisition shall take place at the office of Nylex on or before the date falling 90 days after the Sale of Business Agreement becomes unconditional or is deemed to have become unconditional. As of January 12, 2022, Maybank IB wishes to announce that Nylex has today, obtained the order of the High Court of Malaya confirming the special resolution passed by the shareholders of Nylex on October 26, 2021 approving the reduction of the issued share capital of Nylex and the transaction. The transaction has become unconditional. KAF Investment Bank Berhad acted as financial advisor to Audit Committee of Ancom. Maybank Investment Bank Berhad acted as financial advisor to Ancom. Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) on January 26, 2022.Reported Earnings • Jan 19Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: RM0.043 (up from RM0.026 in 2Q 2021). Revenue: RM385.4m (up 46% from 2Q 2021). Net income: RM7.73m (up 72% from 2Q 2021). Profit margin: 2.0% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 31% per year and the company’s share price has also increased by 31% per year.Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to RM1.44, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 16x in the Chemicals industry in Malaysia. Total returns to shareholders of 127% over the past three years.分析記事 • Dec 27Is Nylex (Malaysia) Berhad (KLSE:NYLEX) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...お知らせ • Dec 10Nylex (Malaysia) Berhad to Be Deleted from Other OTCNylex (Malaysia) Berhad's Ordinary Shares will be deleted from other OTC effective from December 10, 2021 due to Inactive Security.Valuation Update With 7 Day Price Move • Oct 25Investor sentiment improved over the past weekAfter last week's 20% share price gain to RM1.42, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 17x in the Chemicals industry in Malaysia. Total returns to shareholders of 134% over the past three years.Reported Earnings • Oct 04Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM18.9m (up RM42.1m from FY 2020). Profit margin: 1.6% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.分析記事 • Sep 21Nylex (Malaysia) Berhad (KLSE:NYLEX) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Jul 31Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM19.3m (up RM42.5m from FY 2020). Profit margin: 1.7% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.分析記事 • May 06We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Is Taking Some Risk With Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Apr 29Third quarter 2021 earnings released: EPS RM0.028 (vs RM0.021 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: RM289.1m (up 5.0% from 3Q 2020). Net income: RM4.94m (up RM8.62m from 3Q 2020). Profit margin: 1.7% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 121 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Mar 10New 90-day high: RM0.69The company is up 12% from its price of RM0.62 on 10 December 2020. The Malaysian market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period.Reported Earnings • Jan 27Second quarter 2021 earnings released: EPS RM0.026 (vs RM0.002 in 2Q 2020)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: RM263.4m (down 17% from 2Q 2020). Net income: RM4.49m (up RM4.22m from 2Q 2020). Profit margin: 1.7% (up from 0.1% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 109 percentage points per year, which is a significant difference in performance.分析記事 • Jan 15We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Has A Fair Chunk Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Is New 90 Day High Low • Dec 17New 90-day high: RM0.67The company is up 8.0% from its price of RM0.61 on 18 September 2020. The Malaysian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 33% over the same period.分析記事 • Nov 23Here's What We Learned About The CEO Pay At Nylex (Malaysia) Berhad (KLSE:NYLEX)This article will reflect on the compensation paid to Ka Wei Siew who has served as CEO of Nylex (Malaysia) Berhad...Is New 90 Day High Low • Nov 02New 90-day low: RM0.54The company is down 24% from its price of RM0.70 on 04 August 2020. The Malaysian market is down 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.Reported Earnings • Oct 28First quarter earnings releasedOver the last 12 months the company has reported total losses of RM23.6m, with losses widening by 213% from the prior year. Total revenue was RM1.07b over the last 12 months, down 27% from the prior year.Reported Earnings • Oct 01Full year earnings released - RM0.13 loss per shareOver the last 12 months the company has reported total losses of RM23.2m, with losses widening by RM19.8m from the prior year. Total revenue was RM1.14b over the last 12 months, down 27% from the prior year.Is New 90 Day High Low • Sep 29New 90-day low: RM0.56The company is down 15% from its price of RM0.65 on 01 July 2020. The Malaysian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 4.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Nylex (Malaysia) Berhad は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測KLSE:NYLEX - アナリストの将来予測と過去の財務データ ( )MYR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数2/29/20240-2-2-2N/A11/30/20230-2-1-1N/A8/31/20230-2-1-1N/A5/31/20230-2-2-2N/A2/28/2023-93448165163N/A11/30/2022-660-10109N/A8/31/2022-275-1-4-5N/A5/31/2022N/A-1-16-16N/A2/28/2022136-58-186-182N/A11/30/20211514-40-34N/A8/31/2021291-24-19N/A5/31/2021N/A-12631N/A2/28/20211,029-114953N/A11/30/20201,015-198185N/A8/31/20201,068-24103108N/A5/31/20201,136-238793N/A2/29/20201,286-46876N/A11/30/20191,336-74455N/A8/31/20191,455-8-112N/A5/31/20191,560-3-14-2N/A2/28/20191,605209N/A11/30/20181,62414-12-7N/A8/31/20181,553211923N/A5/31/20181,446192830N/A2/28/20181,40220-11-9N/A11/30/20171,42722N/A-20N/A8/31/20171,37822N/A19N/A5/31/20171,33720N/A-22N/A2/28/20171,24820N/A54N/A11/30/20161,13514N/A84N/A8/31/20161,14810N/A37N/A5/31/20161,19711N/A42N/A2/29/20161,2317N/A18N/A11/30/20151,2455N/A37N/A8/31/20151,2376N/A46N/A5/31/20151,2737N/A53N/A2/28/20151,3254N/A67N/A11/30/20141,3808N/A58N/A8/31/20141,5089N/A53N/A5/31/20141,5668N/A77N/A2/28/20141,63111N/A-5N/A11/30/20131,7069N/A-36N/A8/31/20131,7048N/A18N/A5/31/20131,7298N/A-34N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: NYLEXの予測収益成長が 貯蓄率 ( 3.6% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: NYLEXの収益がMY市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: NYLEXの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: NYLEXの収益がMY市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: NYLEXの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: NYLEXの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/05/05 18:57終値2024/02/06 00:00収益2024/02/29年間収益2023/05/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nylex (Malaysia) Berhad 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 08Nylex to Delist from Bursa Malaysia on March 11Nylex (Malaysia) Berhad is set to be delisted from Bursa Malaysia on March 11, following the company’s failure to submit its regularisation plan on time. In a filing with Bursa Malaysia on March 6, 2025, the bourse regulator said it has dismissed the company's appeal for a further extension of six months until July 26, 2025 to submit its regularisation plan to the relevant authorities for approval. As such, Bursa Malaysia said the company would be delisted from Bursa Malaysia after two market days from March 6, that is on March 11, 2025. Upon the de-listing of the company, the company will continue to exist but as an unlisted entity. The company can still continue its operations and businesses and proceed with its corporate restructuring.
お知らせ • Sep 27Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024, at 09:30 Singapore Standard Time. Location: no. 2a, jalan 13/2, seksyen 13, 46200 petaling jaya, selangor darul ehsan, Malaysia
お知らせ • Jan 31Nylex (Malaysia) Berhad Provides Update Related to Suspension & Delisting of SecuritiesRefer to the Nylex (Malaysia) Berhad’s announcements dated 27 January 2022 and 28 January 2022 in relation to the First Announcement and the announcements made on 16 August 2023, 23 August 2023, 13 October 2023 and 26 January 2024. Unless otherwise stated, all abbreviations and definitions used herein shall have the same meanings as those used in the said announcements. The Board announced that Bursa Securities had via its letter dated 29 January 2024 informed the Company that Bursa Securities has noted that: a) Nylex had failed to submit the proposed regularisation plan to the relevant authorities for approval within the extended timeframe of 26 January 2024 as granted by the Listing Committee via its letter dated 13 October 2023 (“LC Decision Letter”); and b) the Company has on 26 January 2024, appealed/applied for a further extension of time ("Appeal"). In the circumstances and pursuant to paragraph 8.03A(3) of the Listing Requirements and the LC Decision Letter, (i) the trading in the securities of Nylex will be suspended with effect from 7 February 2024 ("Suspension Date") even though the decision on the Appeal is still pending. (ii) However, the de-listing of the securities of the Company upon the expiry of 2 market days from the Suspension Date will be deferred pending the decision on the Appeal by Bursa Securities.
New Risk • Jan 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RM40.5m (US$8.55m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM40.5m market cap, or US$8.55m). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change).
お知らせ • Sep 27Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023, at 09:30 Singapore Standard Time. Location: No. 2A, Jalan 13/2, Seksyen 13,46200 Petaling Jaya Selangor Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31 May 2023 together with the Reports of the Directors and the Auditors; To re-elect as Director, Datin Joanne Marie Lopez who is retiring pursuant to Clause 130 of the Company's Constitution; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2023; to approve the payment of Non-Executive Directors' fees for the financial year ending 31 May 2024, to be paid quarterly in arrears; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorise the Directors to fix their remuneration and to consider other business matters.
New Risk • Aug 18New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RM44.9m (US$9.66m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 12% per year over the past 5 years. Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM44.9m market cap, or US$9.66m).
お知らせ • Jun 29+ 9 more updatesNylex (Malaysia) Berhad Announces Redesignation of Edmond Cheah Swee Leng from Chairman of Nomination and Remuneration Committee to Non Independent and Non Executive Member of Nomination and Remuneration CommitteeNylex (Malaysia) Berhad announced redesignation of EDMOND CHEAH SWEE LENG from Chairman of Nomination and Remuneration Committee to Non Independent and Non Executive Member of Nomination and Remuneration Committee. Age 68, Date of change 28 June 2023. Composition of Nomination and Remuneration Committee(Name and Directorate of members after change). Chairman: Datin Joanne Marie Lopez (Independent Non Executive Director) Members: Datuk Anuar Bin Ahmad (Independent Non Executive Director) Edmond Cheah Swee Leng (Non ndependent Non Executive Director).
Board Change • Jan 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 5 highly experienced directors. Independent Non-Executive Director See Yan Lin was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Oct 04Full year 2022 earnings released: RM0.007 loss per share (vs RM0.004 loss in FY 2021)Full year 2022 results: RM0.007 loss per share (further deteriorated from RM0.004 loss in FY 2021). Net loss: RM1.26m (loss widened 70% from FY 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.
お知らせ • Sep 29Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022, at 09:30 Singapore Standard Time. Location: No. 2a, Jalan 13/2, Seksyen 13, 46200 Petaling Jaya Darul Ehsan Selangor Malaysia Agenda: To receive the audited financial statements for the financial year ended 31 May 2022 together with the Reports of the Directors and the Auditors thereon; to re-elect the directors who are retiring by rotation; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2022; to approve the payment of Directors' benefits (excluding Non-Executive Directors' fees) for the Non-Executive Directors from the date of the forthcoming AGM until the next annual general meeting of the Company; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorize the Directors to fix their remuneration; to discuss proposed renewal authority for share buy-back mandate; and to discuss other matters.
Reported Earnings • Jul 20Full year 2022 earnings released: RM0.28 loss per share (vs RM0.11 profit in FY 2021)Full year 2022 results: RM0.28 loss per share (down from RM0.11 profit in FY 2021). Revenue: RM934.1m (down 19% from FY 2021). Net loss: RM50.4m (down 367% from profit in FY 2021). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Apr 21Third quarter 2022 earnings released: RM0.32 loss per share (vs RM0.028 profit in 3Q 2021)Third quarter 2022 results: RM0.32 loss per share (down from RM0.028 profit in 3Q 2021). Revenue: RM273.8m (down 5.3% from 3Q 2021). Net loss: RM57.7m (down RM62.6m from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to RM1.53, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 13x in the Chemicals industry in Malaysia. Total returns to shareholders of 138% over the past three years.
Upcoming Dividend • Mar 01Inaugural dividend of RM0.39 per shareEligible shareholders must have bought the stock before 08 March 2022. Payment date: 23 March 2022. The company is not currently making a profit and is not cash flow positive. The company last paid an ordinary dividend in September 2019. The average dividend yield among industry peers is 4.3%.
お知らせ • Jan 27Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX).Ancom Berhad (KLSE:ANCOM) entered into an agreement to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on July 29, 2021. Ancom Berhad (KLSE:ANCOM) submitted a formal offer to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on April 28, 2021. Out of total consideration, MYR 50 million will be paid in cash and MYR 46.7 million via the issuance of 31,129,508 new Ancom Shares at an issue price of MYR 1.50 per Ancom Share. Post completion of the Proposed Acquisition, Ancom will continue to hold 50.27% equity interest in Nylex. The Cash Consideration will be funded through a bank borrowings. Out of total consideration, Nylex to distribute an amount equivalent to MYR 164.29 million to its shareholders and retain MYR 15 million for its working capital and general corporate purposes. The Proposed Acquisition is subject to approval of the shareholders of Ancom at an extraordinary general meeting to be convened; approval of Bursa Securities for the listing and quotation of the Consideration Shares on the Main Market of Bursa Securities; approval of the shareholders of Nylex at an EGM to be convened; regulatory approvals; approval/consent from financiers/creditors of Ancom, Rhodemark and/or the Nylex Group upon the terms and subject to the conditions of the Sale of Business Agreement, where required; grant of an order of the High Court of Malaya pursuant to Section 116 of the CA 2016 and other closing conditions. As of June 28, 2021, board of Nylex (Malaysia) Berhad accepted the offer. As of August 18, 2021, on behalf of the Ancom Board, Maybank IB wishes to announce that the additional listing application in relation to the Consideration Shares to be issued pursuant to the Proposed Acquisition has been submitted to Bursa Securities. As of September 23, 2021 on behalf of the Ancom Board, Maybank IB wishes to announce that Bursa Securities had via its letter dated September 23, 2021, approved the listing of and quotation for 31,129,508 new ordinary shares in Ancom to be issued pursuant to the Proposed Acquisition, subject to, among others conditions. The Proposal Letter shall remain valid for acceptance by the Nylex Board until 5.00 p.m. on June 28, 2021, unless extended by mutual agreement in writing and the parties are to negotiate and finalise the terms and conditions of the Sale of Business Agreement and enter into the Sale of Business Agreement within 60 days from the date of acceptance of the Proposal Letter (or such other period as the parties may agree in writing). The completion of the Proposed Acquisition shall take place at the office of Nylex on or before the date falling 90 days after the Sale of Business Agreement becomes unconditional or is deemed to have become unconditional. As of January 12, 2022, Maybank IB wishes to announce that Nylex has today, obtained the order of the High Court of Malaya confirming the special resolution passed by the shareholders of Nylex on October 26, 2021 approving the reduction of the issued share capital of Nylex and the transaction. The transaction has become unconditional. KAF Investment Bank Berhad acted as financial advisor to Audit Committee of Ancom. Maybank Investment Bank Berhad acted as financial advisor to Ancom. Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) on January 26, 2022.
Reported Earnings • Jan 19Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: RM0.043 (up from RM0.026 in 2Q 2021). Revenue: RM385.4m (up 46% from 2Q 2021). Net income: RM7.73m (up 72% from 2Q 2021). Profit margin: 2.0% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 31% per year and the company’s share price has also increased by 31% per year.
Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to RM1.44, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 16x in the Chemicals industry in Malaysia. Total returns to shareholders of 127% over the past three years.
分析記事 • Dec 27Is Nylex (Malaysia) Berhad (KLSE:NYLEX) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
お知らせ • Dec 10Nylex (Malaysia) Berhad to Be Deleted from Other OTCNylex (Malaysia) Berhad's Ordinary Shares will be deleted from other OTC effective from December 10, 2021 due to Inactive Security.
Valuation Update With 7 Day Price Move • Oct 25Investor sentiment improved over the past weekAfter last week's 20% share price gain to RM1.42, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 17x in the Chemicals industry in Malaysia. Total returns to shareholders of 134% over the past three years.
Reported Earnings • Oct 04Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM18.9m (up RM42.1m from FY 2020). Profit margin: 1.6% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.
分析記事 • Sep 21Nylex (Malaysia) Berhad (KLSE:NYLEX) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Jul 31Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM19.3m (up RM42.5m from FY 2020). Profit margin: 1.7% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
分析記事 • May 06We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Is Taking Some Risk With Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Apr 29Third quarter 2021 earnings released: EPS RM0.028 (vs RM0.021 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: RM289.1m (up 5.0% from 3Q 2020). Net income: RM4.94m (up RM8.62m from 3Q 2020). Profit margin: 1.7% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 121 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Mar 10New 90-day high: RM0.69The company is up 12% from its price of RM0.62 on 10 December 2020. The Malaysian market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period.
Reported Earnings • Jan 27Second quarter 2021 earnings released: EPS RM0.026 (vs RM0.002 in 2Q 2020)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: RM263.4m (down 17% from 2Q 2020). Net income: RM4.49m (up RM4.22m from 2Q 2020). Profit margin: 1.7% (up from 0.1% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 109 percentage points per year, which is a significant difference in performance.
分析記事 • Jan 15We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Has A Fair Chunk Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Is New 90 Day High Low • Dec 17New 90-day high: RM0.67The company is up 8.0% from its price of RM0.61 on 18 September 2020. The Malaysian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 33% over the same period.
分析記事 • Nov 23Here's What We Learned About The CEO Pay At Nylex (Malaysia) Berhad (KLSE:NYLEX)This article will reflect on the compensation paid to Ka Wei Siew who has served as CEO of Nylex (Malaysia) Berhad...
Is New 90 Day High Low • Nov 02New 90-day low: RM0.54The company is down 24% from its price of RM0.70 on 04 August 2020. The Malaysian market is down 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.
Reported Earnings • Oct 28First quarter earnings releasedOver the last 12 months the company has reported total losses of RM23.6m, with losses widening by 213% from the prior year. Total revenue was RM1.07b over the last 12 months, down 27% from the prior year.
Reported Earnings • Oct 01Full year earnings released - RM0.13 loss per shareOver the last 12 months the company has reported total losses of RM23.2m, with losses widening by RM19.8m from the prior year. Total revenue was RM1.14b over the last 12 months, down 27% from the prior year.
Is New 90 Day High Low • Sep 29New 90-day low: RM0.56The company is down 15% from its price of RM0.65 on 01 July 2020. The Malaysian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 4.0% over the same period.